Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000103623-24-000076
Filing Date
2024-09-20
Accepted
2024-09-20 16:13:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4706
  Complete submission text file 0000103623-24-000076.txt   6120
Mailing Address 286 STANWICH ROAD GREENWICH CT 06830
Business Address
SINGLETON J MATTHEW (Reporting) CIK: 0001243514 (see all company filings)

Type: 144

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37355 | Film No.: 241313514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)